Keyword: Elan takeover

News

Divisive Elan Boss Martin Faces Ownership Showdown

13.06.2013 - When Kelly Martin, a former Merrill Lynch banker with no drug industry experience, took over as CEO of Ireland's Elan in 2003, analysts assumed his mandate was to clean up the...

News

Ruling Threatens Royalty's Elan Bid Ahead of Key Meeting

07.06.2013 - Royalty Pharma received a blow in its battle to take over Irish drug firm Elan on Thursday after a ruling on conditions attached to the U.S. company's hostile bid threatened to...

News

Elan Strikes $1 Billion Royalty Deal with Theravance

13.05.2013 - Elan stepped up its bid to keep its independence on Monday by agreeing a $1 billion deal to buy 21% of the royalties that U.S. company Theravance receives from GlaxoSmithKline for...

News

Elan Board Unanimously Rejects Royalty Pharma Bid

22.04.2013 - The board of Irish drugmaker Elan unanimously rejected a formal bid from Royalty Pharma on Monday, saying the U.S. investment firm's offer of $11.25 a share grossly undervalues the...

News

J&J Stake Sale Clouds Royalty Bid for Elan

19.04.2013 - U.S. healthcare firm Johnson & Johnson cut its stake in Elan on Thursday in a move that clouds prospects for a $7.3 billion takeover bid for the Irish drugmaker. U.S. investment...

News

Royalty Pharma Considers Sweetened Deal for Elan

12.04.2013 - U.S. investment firm Royalty Pharma is considering sweetening its $6.6 billion offer for Irish drugmaker Elan by paying Elan shareholders more if the multiple sclerosis drug...

News

Elan to Start Share Buyback Next Week

10.03.2013 - Drugmaker Elan is to bring forward a planned $1 billion share buyback to next week, the Irish company said in a statement, a move that could undermine a takeover offer by U.S...

News

Royalty Pharma Proposes $6.6 Billion Bid for Elan

25.02.2013 - Investment firm Royalty Pharma has made a $6.6 billion bid approach to Elan, seeking to scupper the Irish drugmaker's plan to spend most of the proceeds from a major drug sale on...